Investigating the medical journey of endometriosis-affected women: results from a cross-sectional web-based survey (EndoVie) on 1,557 French women

Abstract

OBJECTIVE: To investigate the medical journey and the quality of life of French endometriosis-affected women, from the onset of the symptoms to the therapeutic management. STUDY DESIGN: Between January 15th 2020 and February 3rd 2020, a prospective cross-sectional web-based survey was conducted among women diagnosed with endometriosis. The questionnaire included 52 questions distributed in five sections (screening, sociodemographic characteristics, impacts on quality of life, SF36 questionnaire, management of endometriosis and proposals for care improvement). RESULTS: One thousand five hundred fifty-seven endometriosis-affected women aged of 42±12.8 years answered the questionnaire. On average, 7 years elapsed between the first symptoms (at 23.8±10.2 years) and the diagnosis (31.0±8.9 years). The mean number of symptoms was 4.6±2.3, with 82% of women experiencing pain scores between 7 and 10/10. Following diagnosis, 66% women received a medical treatment, mostly hormonal treatments (45%), with a significant decrease in pain intensity (VAS scores after treatment = 4.9±2.7, p<0.001). Most women (62%) had already been operated, among whom 22% by laparotomy. Finally, patients reported numerous impacts on their daily lives, particularly on the sexual, psychological, and physical fields. The overall mean score of quality of life was 4.3±2.6 /10. CONCLUSION: This large prospective web-based survey underlines that the journey of women with endometriosis is long and difficult until diagnosis and efficient treatment. It emphasizes the urgent need to reduce the diagnostic delay and thereby the burden of endometriosis on women's lives. Moreover, the creation of referral multidisciplinary centers appears to be crucial to improve the management of the disease.